These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 6118281

  • 1. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
    Costall B, Lim SK, Naylor RJ.
    Eur J Pharmacol; 1981 Jul 17; 73(2-3):175-88. PubMed ID: 6118281
    [Abstract] [Full Text] [Related]

  • 2. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B, Eniojukan JF, Naylor RJ.
    Eur J Pharmacol; 1983 Dec 23; 96(3-4):201-10. PubMed ID: 6426976
    [Abstract] [Full Text] [Related]

  • 3. Inhibition and facilitation of motor responding of the mouse by actions of dopamine agonists in the forebrain.
    Bradbury AJ, Costall B, Naylor RJ.
    Neuropharmacology; 1984 Sep 23; 23(9):1025-31. PubMed ID: 6514141
    [Abstract] [Full Text] [Related]

  • 4. Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.
    Costall B, Naylor RJ, Nohria V.
    Eur J Pharmacol; 1978 Jul 01; 50(1):39-50. PubMed ID: 28233
    [Abstract] [Full Text] [Related]

  • 5. Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvement.
    Costall B, Eniojukan JF, Naylor RJ.
    Eur J Pharmacol; 1982 Nov 19; 85(2):125-32. PubMed ID: 7151866
    [Abstract] [Full Text] [Related]

  • 6. Reduction in motor responding of the mouse by actions of dopamine agonists in the midbrain.
    Bradbury AJ, Costall B, Naylor RJ.
    Neuropharmacology; 1983 Oct 19; 22(10):1171-6. PubMed ID: 6646352
    [Abstract] [Full Text] [Related]

  • 7. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
    Costall B, Eniojukan JF, Naylor RJ.
    Psychopharmacology (Berl); 1985 Oct 19; 86(4):452-7. PubMed ID: 3929317
    [Abstract] [Full Text] [Related]

  • 8. A central site of dopamine agonist action to modify gastric secretion in the rat.
    Costall B, Naylor RJ, Tan CC.
    Eur J Pharmacol; 1985 Oct 29; 117(1):61-9. PubMed ID: 2867911
    [Abstract] [Full Text] [Related]

  • 9. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99.
    Martin GE, Haubrich DR, Williams M.
    Eur J Pharmacol; 1981 Nov 19; 76(1):15-23. PubMed ID: 7318920
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological evidence for the subclassification of central dopamine receptors in the rat.
    Gower AJ, Marriott AS.
    Br J Pharmacol; 1982 Sep 19; 77(1):185-93. PubMed ID: 6889902
    [Abstract] [Full Text] [Related]

  • 11. Dopamine analog-induced hyperglycemia in rats: involvement of the adrenal medulla and the endocrine pancreas.
    Arnerić SP, Chow SA, Long JP, Fischer LJ.
    J Pharmacol Exp Ther; 1984 Mar 19; 228(3):551-9. PubMed ID: 6142939
    [Abstract] [Full Text] [Related]

  • 12. Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
    Martin GE, Bendesky RJ.
    J Pharmacol Exp Ther; 1984 Jun 19; 229(3):706-11. PubMed ID: 6144790
    [Abstract] [Full Text] [Related]

  • 13. [Comparative study of the pharmacological properties of sultopride sulpiride and other antipsychotic drugs: influence of sultopride, sulpiride and other antipsychotic drugs on spontaneous locomotor activity and changes in locomotor activity induced by apomorphine and clonidine in mice].
    Horikomi K, Fujita M.
    Yakubutsu Seishin Kodo; 1986 Sep 19; 6(3):339-52. PubMed ID: 2880435
    [Abstract] [Full Text] [Related]

  • 14. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J, Briley M, Langer SZ.
    Eur J Pharmacol; 1983 Mar 18; 88(1):11-26. PubMed ID: 6133762
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of action of apomorphine on rat gastric secretion.
    Costall B, Naylor RJ, Tan CC.
    Eur J Pharmacol; 1985 Oct 22; 116(3):279-85. PubMed ID: 2866967
    [Abstract] [Full Text] [Related]

  • 16. DPI, a supposed selective agonist of inhibitory dopamine receptors, strongly increases rat diuresis through alpha-adrenergic receptor activation.
    Baggio G, Ferrari F.
    Life Sci; 1981 Mar 30; 28(13):1449-56. PubMed ID: 6113526
    [No Abstract] [Full Text] [Related]

  • 17. On the preferred rotameric conformation for dopamine agonist action: an illusory quest.
    Costall B, Lim SK, Naylor RJ, Cannon JG.
    J Pharm Pharmacol; 1982 Apr 30; 34(4):246-54. PubMed ID: 6124599
    [Abstract] [Full Text] [Related]

  • 18. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb 30; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 19. Prejunctional dopamine receptors modulate twitch responses to parasympathetic nerve stimulation in the rabbit isolated rectococcygeus muscle.
    Drew GM, Hilditch A.
    Br J Pharmacol; 1984 Dec 30; 83(4):871-81. PubMed ID: 6151412
    [Abstract] [Full Text] [Related]

  • 20. Interaction of the component enantiomers of the putative dopamine autoreceptor agonist, TL-99 (6,7-dihydroxy-2-dimethylamino tetralin) with dopaminergic systems in mammalian brain and teleost retina.
    Williams M, Martin GE, McClure DE, Baldwin JJ, Watling KJ.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Dec 30; 324(4):275-80. PubMed ID: 6141532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.